Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions

Journal of Nuclear Medicine

Volumn 39, Issue 1, 1998, Pages 86-91

  Mekhmandarov, Sergey ^a   Sandbank, Judith ^b   Cohen, Maya ^b   Lelcuk, Shlomo ^b   Lubin, Ernesto ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Breast cancer; Scintimammography; Technetium 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCINTISCANNING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TUMOR VOLUME;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; MALE; MIDDLE AGED; PALPATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0031881848     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ries IAG, Miller BA, Hankey BA, et al. Seer cancer statistics review, 1973-1991. Publication no. 94-2789. Bethesda, MD: National Cancer Institute; 1994.
2. Sondik ES. Breast cancer trends. Incidence, mortality and survival Cancer 1994;74: 995-999.
3. Garfinkel L, Boring CC, Heath CW. Changing trends. An overview of breast cancer and mortality. Cancer 1994;74:222-227.
4. Leborgne R. Diagnosis of tumors of the breast by simple roentgenography - calcifications in carcinomas. Am J Roentgenol 1951;65:1-11.
5. Sikles EA. Mammographic feature of 300 consecutive nonpalpable breast cancers. Am J Roentgenol 1986;146:661-666.
6. Jackson VP, Hendrick RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology 1993;188:297-301.
7. Kopans DB. The positive predictive value of mammography. Am J Roentgenol 1992;158:521-526.
8. Burak Z, Argon M, Memis A, et al. Evaluation of palpable breast masses with Tc-99m MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604-612.
9. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-436.
10. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up J Nucl Med 1995;36: 1784-1789.
11. Khalkhali I, Cutrone JA, Mena IC, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
12. Taillefer R, Robidoux A, Lambert R, et al. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
13. Waxman A, Nagarai N, Kovalevsky M, et al. Detection of primary breast malignancy with Tc-99m methoxyisobutylisonitrile (MIBI) in patients with non-palpable primary malignancies: the importance of lesion size [Abstract]. J Nucl Med 1995;36:194P.
14. Khalkhali I, Mena I, Jouanne E, et al. Prone Scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491-497.
15. Hisada K, Tonami N, Miyamae T, et al. Clinical evaluation of tumor imaging with T1-201 chloride. Radiology 1978;129:497-500.
16. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
17. Muller ST, Reiners C, Pass M, et al. Technetium-99m MIBI and thallium-201 uptake in bronchial carcinoma [Abstract]. Eur J Nucl Med 1989;33:84.
18. 99mTc by human carcinoma cell lines in vitro. Cancer Res 1990;50:2198-2202.
19. Maffioli L, Agresti R, Chili A, et al. Prone scintimammography in patients with non-palpable breast lesions. Anticancer Res 1996;16:1269-1273.
20. Tiling R, Pechmann M, Sommer H, et al. Does SPECT improve the diagnostic accuracy of planar scintimammography with sestamibi? [Abstract] J Nucl Med 1996;37:252P.
21. Ryu JS, Choi YY, Yang S-O, et al. Technetium-99m-sestamibi imaging in the evaluation of breast cancer and axillary lymphadenopathy: comparison of planar and SPECT imaging [Abstract]. J Nucl Med 1996;37:252P.